VVD-130850

· Vividion Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVD-130850, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors [Phase 1]

See pricing